Immune Status in Solid Organ Transplantation

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Organ Transplants

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Impending kidney transplant
Age >18
Able to provide informed consent and comply with the study procedures

Exclusion criteria

Age<18
Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial

Treatment and study plan

Primary outcomes

Immune Markers

Time frame: 0, 3, 6, 9, 12 months

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Collaborators

Astellas Pharma Inc

Registry information

Official study title

Evaluation of Predictors of Immune Status in Solid Organ Transplantation

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Feb 18, 2010
Registry last updated: Feb 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed